Latamoxef is a type of antibiotic that contains a cephalosporin. It is effective against many Gram-negative rods (see Gram staining). Latamoxef belongs to the group of beta-lactam antibiotics.
Latamoxef has a bactericidal effect by inhibiting the synthesis of bacterial cell walls. It is active against gram-negative bacteria such as E. coli, Klebsiella spp., Enterobacter spp., Proteus spp., as well as some gram-positive bacteria (staphylococci, streptococci).
Latamoxef is used to treat infections of the respiratory tract, urinary tract, skin and soft tissue.
Latamoxef is available in the form of tablets and powder for oral suspension. The trade name of the drug is Moxalactam.
Latamoxef, also known as Mochalactam, is a type of antibiotic that contains cephalosporins. This antibiotic is effective against many gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and others.
Latamoxef was developed in the 1970s and was one of the first antibiotics that was effective against many types of bacteria, including those that are resistant to other antibiotics.
One of the main advantages of latamoxef is that it does not induce resistance in bacteria, so it can be used to treat infections caused by bacteria that are resistant to other antibiotics, including penicillins and cephalosporins.
However, like other antibiotics, latamoxef can cause side effects such as nausea, vomiting, diarrhea and headache. In addition, it may interact with other medications, so you should consult your doctor before starting treatment.